Analytical Sciences
Online ISSN : 1348-2246
Print ISSN : 0910-6340
ISSN-L : 0910-6340
Original Papers
A Validated Spectrofluorimetric Method for the Determination of Moxifloxacin in Its Pure Form, Pharmaceutical Preparations, and Biological Samples
Muhammad Naeem KHANWaqar ALIZarbad SHAHMuhammad IDREESHussain GULABADNAN
Author information
JOURNALS FREE ACCESS

2020 Volume 36 Issue 3 Pages 361-366

Details
Abstract

This research work presents a simple, sensitive, selective, economic, and widely applicable and interferences-free spectrofluorimetric method estimating moxifloxacin in the pure form, commercial formulations and biological samples. The method is based on the reaction of moxifloxacin with Ce(IV) in an acidic medium to generate fluorescent active species Ce(III). The excitation and emission of the fluorescent species are 250 and 362 nm, respectively. Different variables that might influence the oxidation of moxifloxacin, including the Ce(IV) concentration and volume, the effect of temperature and the heating time, the type of acids and its concentration were analyzed and boosted. The linearity was observed in the concentration range of 0.2 – 5.0 μg mL−1 with a correlation coefficient of 0.9991. The limit of detection and the limit of quantification were calculated and observed to be 0.016 and 0.056 μg mL−1 respectively. The effects of the common excipients and some co-administrated drugs usually used in the determination of moxifloxacin were investigated, and no interferences were noted. The planned method has been successfully practical for the analysis of moxifloxacin in its pure form, in pharmaceutical products and in biological samples. The obtained percent recoveries ranged from 95.50 to 101.37% for pharmaceutical products and from 95.15 to 103.18% for human blood plasma and urine.

Fullsize Image
Information related to the author
© 2020 by The Japan Society for Analytical Chemistry
Previous article Next article
feedback
Top